HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Epithelioid Sarcoma

Epithelioid Sarcoma

Epithelioid Sarcoma is a rare and aggressive form of soft tissue cancer that typically affects young adults. Despite its rarity, research efforts are crucial due to its high recurrence rate and limited treatment options. Cancer researchers are investigating various aspects of epithelioid sarcoma, including its molecular mechanisms, genetic mutations, and potential therapeutic targets. Advanced imaging techniques and genomic profiling help in early detection and personalized treatment strategies. Clinical trials exploring novel therapies such as targeted drugs and immunotherapies offer hope for improved outcomes. Collaborative efforts among researchers, clinicians, and patients are essential for advancing our understanding of epithelioid sarcoma and developing effective treatments to combat this challenging disease.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp